NEW YORK, April 06, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Omega Protein Corporation securities (NYSE:OME) from August 3, 2016 through March 1, 2017, both dates inclusive (the “Class Period”) of the important May 2, 2017 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Omega investors under the federal securities laws.
To join the Omega class action, go to http://www.rosenlegal.com/cases-1069.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the SEC is requesting information in connection with an investigation relating to Omega’s subsidiary’s compliance with its probation terms and Omega’s protection of whistleblower employees; (2) it is possible that the foregoing matter could result in a material adverse effect on Omega’s business, reputation, results of operation and financial condition; and (3) as a result, Defendants’ statements about Omega’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1069.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm. Attorney Advertising. Prior results do not guarantee a similar outcome.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 



